Trials / Completed
CompletedNCT00868842
Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis
Open-label, Single-center Study of Whether Oral Penicillin Desensitization of Healthy Sensitive Subjects Results in Allergen Cross-desensitization of Mast Cells by Skin Testing and Desensitization of Peripheral Blood Basophils.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is an open-label, single-center study of whether oral penicillin desensitization of healthy sensitive subjects results in allergen cross-desensitization of mast cells by skin testing and desensitization of peripheral blood basophils. The primary endpoint(s) will be PC3 prick skin test values to penicillin, aeroallergen(s) and codeine. Secondary endpoints will be levels of Syk in purified basophils determined by flow cytometry (mean fluorescence intensity) and basophil degranulation (% tryptase release) to anti-FcåRI and to calcium ionophore.
Conditions
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2012-05-01
- Completion
- 2012-06-01
- First posted
- 2009-03-25
- Last updated
- 2014-04-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00868842. Inclusion in this directory is not an endorsement.